article · Kidney International Reports
Transforming growth factor-beta (TGF-β) has both fibrotic and protective roles; as a mediator of fibrosis, it can serve as a novel biomarker for early diagnosis and prediction of chronic kidney disease (CKD) progression. Chronic kidney disease (CKD) can occur silently and progress to end stage kidney disease (ESKD) in resource constrained settings.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.ekir.2024.11.343
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
